{"id":25328,"date":"2025-09-03T09:30:00","date_gmt":"2025-09-03T09:30:00","guid":{"rendered":"https:\/\/www.caplinpoint.net\/?p=25328"},"modified":"2025-09-18T13:10:21","modified_gmt":"2025-09-18T13:10:21","slug":"caplin-steriles-gets-usfda-approval-for-milrinone-lactate-in-5-dextrose-injection-infusion-bags","status":"publish","type":"post","link":"https:\/\/www.caplinpoint.net\/index.php\/2025\/09\/03\/caplin-steriles-gets-usfda-approval-for-milrinone-lactate-in-5-dextrose-injection-infusion-bags\/","title":{"rendered":"CAPLIN STERILES GETS USFDA APPROVAL FOR MILRINONE LACTATE IN 5% DEXTROSE INJECTION, INFUSION BAGS"},"content":{"rendered":"\n<p><strong>Chennai, Sep 3rd, 2025: Caplin Steriles Limited (Caplin),<\/strong> a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Milrinone Lactate in 5% Dextrose Injection, 20 mg\/100 mL (0.2 mg\/mL) and 40 mg\/200 mL (0.2 mg\/mL) Single-dose Infusion Bags, a generic therapeutic equivalent version of the Reference Listed Drug (RLD) PRIMACOR in Dextrose 5%, by Sanofi Aventis US LLC.<\/p>\n\n\n\n<p>Milrinone is indicated for the short-term intravenous treatment of patients with acute decompensated heart failure. According to IQVIATM (IMS Health), Milrinone Lactate in 5% Dextrose Injection had US sales of approximately $11 million for the 12-month period ending July 2025.<\/p>\n\n\n\n<div class=\"wp-block-file\"><a target=\"_blank\" href=\"https:\/\/www.caplinpoint.net\/wp-content\/uploads\/2025\/04\/Press_Release__sd.pdf\" class=\"wp-block-file__button\" rel=\"noopener\">Source<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Chennai, Sep 3rd, 2025: Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT), has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Milrinone Lactate in 5% Dextrose Injection, 20 mg\/100 mL (0.2 mg\/mL) and 40&#8230; <\/p>\n","protected":false},"author":1,"featured_media":1229,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/25328"}],"collection":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/comments?post=25328"}],"version-history":[{"count":2,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/25328\/revisions"}],"predecessor-version":[{"id":25330,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/posts\/25328\/revisions\/25330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media\/1229"}],"wp:attachment":[{"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/media?parent=25328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/categories?post=25328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caplinpoint.net\/index.php\/wp-json\/wp\/v2\/tags?post=25328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}